| 2022 | | A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres | 노태훈 |
| 2011 | | A pustular form of eosinophilic, polymorphic, and pruritic eruption associated with radiotherapy. | 김유찬 |
| 2015 | | Adenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cells. | 최경숙 |
| 2004 | | Analysis of prognostic factors in the patients with glioblastoma | 강성원, 김세혁, 안영환, 윤수한, 조경기, 조기홍 |
| 2020 | | Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy | 노태훈 |
| 2024 | | Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients With Recurrent Glioblastoma: A Nationwide Population-Based Study | 김세혁, 노태훈 |
| 2020 | | Characterization of orthotopic xenograft glioblastoma models | 서해영, 한지훈 |
| 2020 | | Chemoradiation in elderly patients with glioblastoma from the multi-institutional GBM-molRPA cohort: is short-course radiotherapy enough or is it a matter of selection? | 오영택 |
| 2020 | | CXCR4-STAT3 Axis Plays a Role in Tumor Cell Infiltration in an Orthotopic Mouse Glioblastoma Model | 김성수, 서해영, 윤정선 |
| 2013 | | Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy. | 오영택 |
| 2010 | | Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions. | 김상현, 조경기 |
| 2005 | | Downregulation of GFAP, TSP-1, and p53 in human glioblastoma cell line, U373MG, by IE1 protein from human cytomegalovirus. | 김승업 |
| 2023 | | Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study) | 김세혁 |
| 2019 | | Epigenetic downregulation of STAT6 increases HIF-1alpha expression via mTOR/S6K/S6, leading to enhanced hypoxic viability of glioma cells | 김세혁, 김현미, 박수정, 조은혜, 주일로 |
| 2017 | | Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma | 모정순 |
| 2011 | | Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells. | 김세혁 |
| 2023 | | Involvement of THO Complex 2 in the 5-Fluorouracil Resistance of Human Glioblastoma Cells | 서해영, 이영준 |
| 2022 | | Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study | 김세혁 |
| 2017 | | Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis | 노태훈 |
| 2018 | | Multiple systemic extraneural metastasis of glioblastoma | 노태훈 |
| 2012 | | Pathologic diagnosis of recurrent glioblastoma: morphologic, immunohistochemical, and molecular analysis of 20 paired cases | 김보영, 김세혁, 김영배, 김장희, 신승수, 이기범, 이현우, 정선용, 한재호 |
| 2013 | | Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. | 우현구 |
| 2018 | | Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation | 김세혁 |
| 2013 | | Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas. | 이다근 |
| 2020 | | Quercetin and chloroquine synergistically kill glioma cells by inducing organelle stress and disrupting Ca(2+) homeostasis | 최경숙 |
| 2015 | | Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance. | 김세혁, 우현구 |
| 2013 | | RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis. | 박선 |
| 2019 | | Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target | 이진구 |
| 2022 | | SHMT1 siRNA-Loaded hyperosmotic nanochains for blood-brain/tumor barrier post-transmigration therapy | 정연훈 |
| 2023 | | SMO-CRISPR-mediated apoptosis in CD133-targeted cancer stem cells and tumor growth inhibition | 정연훈 |
| 2016 | | Suppression of 14-3-3gamma-mediated surface expression of ANO1 inhibits cancer progression of glioblastoma cells | 김철호, 이복순 |
| 1997 | | The Effect of All-trans and 13-cis-retinoic Acid in Medulloblastoma and Glioblastoma Cell Culture | 김성환, 김세혁, 안영환, 윤수한, 조경기, 조기홍 |
| 2020 | | Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma | 우현구 |
| 2020 | | Treatment Results for Recurrent Glioblastoma and Alteration of Programmed Death-Ligand 1 Expression After Recurrence | 노태훈 |
| 2020 | | Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial | 김세혁 |
| 2017 | | Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma | 김세혁, 우현구 |
| 2018 | | Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: A multi-institutional collaborative study | 오영택, 조오연 |
| 2015 | | Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups. | 이다근 |
